Tandem’s Basal-IQ Gets FDA Interoperable Designation
Insulin Nation
APRIL 30, 2020
Tandem’s Basal-IQ technology received the FDA’s interoperable automated glycemic controller designation (iAGC) which allows this tech to be paired with different pumps and CGM systems to create an automated insulin dosing (AID) system. This is the second piece of tech from Tandem to receive such designation. Tandem’s Basal-IQ.
73 
Let's personalize your content